News

Researchers: Delayed treatment of bird flu may raise risk of drug-resistance
A group of researchers says delayed treatment of a type of bird flu now spreading on dairy farms in the United States may ...
Pacific Daily News1d
Public Health urges actions against flu, COVID-19, RSV
The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...
China Daily3d
Domestic single-dose flu drug approved
The first and most widely used single-dose antiviral flu pill is baloxavir marboxil, marketed as Xofluza and developed by the ...
Medical Dialogues11d
Long-Acting experimental Influenza Drug Shows Strong Protection, may outperform Vaccines: Study
A new long-acting influenza drug by Cidara Therapeutics demonstrated up to 76% protection against symptomatic flu in a phase ...
News-Medical.Net on MSN1d
Lipoxygenase emerges as a promising antiviral agent against severe fever with thrombocytopenia syndrome
Severe fever with thrombocytopenia syndrome (SFTS) was reported in Asia, with a fatality rate that can reach as high as 50%.
Antiviral Drugs Market Set to Reach USD 86.59 Billion by 2032, Driven by Rising Chronic Infections and Demand for Targeted Therapies - SNS Insider
U.S. Antiviral Drugs Market to Surpass USD 27.07 Billion by 2032, Fueled by Chronic Infection Treatment Demand and Strong R&D Ecosystem.Austin, July 17, 2025 (GLOBE NEWSWIRE) -- Antiviral Drugs Market ...
Pulmonology Advisor11d
Prescribing Patterns of Influenza Antivirals Show Treatment Gaps in High-Risk Patients
The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.